PU.1 is a transcription factor that plays a critical role throughout hematopoiesis. PU.1 was initially described as the causative oncogene in murine erythroleukemias (28). PU.1 is absolutely required for the development of several myeloid lineages as well as B lymphocytes. In these lineages PU.1 regulates the expression of many genes required for terminally differentiated cells to function (reviewed in (9)). PU.1 also plays a role in the development of lineages such as T lymphocytes and red blood cells where PU.1 is not expressed in mature cells. In these lineages PU.1 is expressed in early progenitors and facilitates their differentiation (15, 40). Indeed, PU.1 even plays a pivotal role in the hematopoietic stem cell. It is required for the proper engraftment and maintenance of HSC in the bone marrow microenvironment (8). As a community we still have a very limited understanding of how HSC progress to become lineage committed progenitors that give rise to the distinct functional cells of the hematopoietic system. We know that developmental changes take place in the HSC and that a variety of multipotent progenitors are produced that lack the ability to self-renew. In addition, we have recently proven that adult HSC can robustly function as hemangioblasts (13) - that is make both blood and blood vessels. We have also developed a new model for hematopoietic stem cell (LSC or oval cell) based liver regeneration in the mouse. In this system PU.1-/- HSC produce hepatocytes better than WT HSC. This may be due to the inability of PU.1-/- HSC to make blood, thereby being encouraged to make liver. To control and follow PU.1 function we have knocked-in a Tamoxifen inducible PU.1 fusion protein (PUERT) and both gfp and LacZ to the PU.1 locus. These models and tools will allow us to further dissect the role of PU.1 in stem cell fate and differentiation. In this proposal we will address the following Specific Aims:
Aim 1. Is PU.1 linked to the initial development of the definitive and transplantable HSC? Aim 2. Define the role of PU.1 in the transition from fetal HSC to adult HSC phenotype? Is this transition reversible? Is PU.1 required to establish marrow hematopoiesis? Aim 3. Does PU.1 influence the developmental fate of adult stem cells?

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Mufson, R Allan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Florida
Schools of Medicine
United States
Zip Code
Slayton, William B; Li, Xiao-Miao; Butler, Jason et al. (2007) The role of the donor in the repair of the marrow vascular niche following hematopoietic stem cell transplant. Stem Cells 25:2945-55
Marshall 2nd, Gregory P; Laywell, Eric D; Zheng, Tong et al. (2006) In vitro-derived ""neural stem cells"" function as neural progenitors without the capacity for self-renewal. Stem Cells 24:731-8
Harris, Jeffrey R; Brown, Gary A J; Jorgensen, Marda et al. (2006) Bone marrow-derived cells home to and regenerate retinal pigment epithelium after injury. Invest Ophthalmol Vis Sci 47:2108-13
Slayton, William B; Wainman, David A; Li, Xiao Miao et al. (2005) Developmental differences in megakaryocyte maturation are determined by the microenvironment. Stem Cells 23:1400-8
Fisher, Robert C; Slayton, William B; Chien, Christopher et al. (2004) PU.1 supports proliferation of immature erythroid progenitors. Leuk Res 28:83-9
Cogle, Christopher R; Wainman, David A; Jorgensen, Marda L et al. (2004) Adult human hematopoietic cells provide functional hemangioblast activity. Blood 103:133-5
Grant, Maria B; Caballero, Sergio; Brown, Gary A J et al. (2003) The contribution of adult hematopoietic stem cells to retinal neovascularization. Adv Exp Med Biol 522:37-45
Grant, Maria B; May, W Stratford; Caballero, Sergio et al. (2002) Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8:607-12
Guerriero, A; Langmuir, P B; Spain, L M et al. (2000) PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. Blood 95:879-85
Wang, X; Scott, E; Sawyers, C L et al. (1999) C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood 94:560-71

Showing the most recent 10 out of 14 publications